Skip to content

Comparation of treatments of temporomandibular joint problems

Comparative study of temporomandibular disfunction therapies: randomized blind controled clinical trials - TMD: temporomandibular disfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5dsrhv
Enrollment
Unknown
Registered
2018-05-18
Start date
2015-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular joint disorders

Interventions

-24 -24 Woman in night use of intra-oral occlusal splint
it consists in an intra-oral device made after the upper and lower arch mold of each patient in acrylic resin. patients used it during night sleep for four months and it received adjustments every fif
- 24 Woman in acupuncture group, weekly sessions performed individually to each patient by acupuncturist dentists according to the principles of the traditional chinese medicine. - 24 Woman in control
Device
Other
H02.004

Sponsors

Faculdade de Odontologia da Universidade Federal do Ceará
Lead Sponsor
Faculdade de Odontologia da Universidade Federal do Ceará
Collaborator
Universidade Federal do Ceará
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Female gender; age between 18 and 59 years; diagnosis temporomandibular dysfunction; adequate bilateral occlusal contacts between molars and premolars; history of orofacial pain, at least during the last 6 months; absence of previous treatment for pain; pain intensity equal to or greater than 7 on a visual analogue scale from 0 to 10; good receptivity and understanding of spoken Portuguese; ability to provide free and informed consent; and availability for attendance to evaluation returns

Exclusion criteria

Exclusion criteria: Abuse of alcohol or illicit drugs; use of antidepressant or antipsychotic medications in the three months prior to the survey; hypersensitivity to the drugs proposed in the research; history of rheumatic or vascular disease; neurological disorders or any systemic base disorders; patients with motor or mental disorders; pregnant women, and patients who suffered some type of macro or microtrauma on the face

Design outcomes

Primary

MeasureTime frame
After treatments, decrease of pain intensity reported by patients, through Visual Analogic Scale, from 0 to 10 and increase of pain threshold to pressure through digital algometer;The results show decrease of pain intensity reported by patients, through Visual Analogic Scale, from 0 to 10 and increase of pain threshold to pressure through digital algometer

Secondary

MeasureTime frame
Expected improvement of the quality of life by the questioning OHIP-30, measured before and after 4 months;It was expected to improve the quality of sleep by the question of Pittsburgh, measured before and after 4 months;Was expected decrease of depression by the questioning back inventory depression, measured before and after 4 months;There was improvement in the quality of life and depression in the amitriptyline and multimodal groups, when compared to the control group;There was improvement in the quality of sleep in the acupuncture group, when compared to the control group

Countries

Brazil

Contacts

Public ContactKadidja Maia e Machado

Faculdade de Odontologia da Universidade Federal do Ceará

kadidjamachado@hotmail.com+55 - 085 - 999249400

Outcome results

None listed

Source: REBEC (via WHO ICTRP)